We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
Outlines a more focused, cost-effective approach to MRSA screening whilst concentrating on reducing infections and improving patient health.
Surveillance of meticillin resistant Staphlyococcus aureus (MRSA) in patients with renal failure.
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: June 2023 to June 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: March 2023 to March 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: August 2023 to August 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: September 2023 to September 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: May 2023 to May 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: April 2023 to April 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: October 2023 to October 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: July 2023 to July 2024
Deaths where meticillin-resistant Staphylococcus aureus (MSA) was mentioned on the death certificate: by sex, age group and place of death, in England and Wales. National data are available from 1993 onwards.
Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection reported by independent sector healthcare organisations, with accompanying commentary.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.